NEPHROGENEX
NephroGenex is a drug-development company focusing on kidney disease. The Company is developing Pyridorinâ„¢ (pyridoxamine dihydrochloride) as a treatment to slow the progression of diabetic kidney disease.
NEPHROGENEX
Industry:
Biotechnology Diabetes Health Care
Founded:
2004-01-01
Address:
Princeton, New Jersey, United States
Country:
United States
Website Url:
http://www.nephrogenex.com
Total Employee:
11+
Status:
Active
Contact:
609-986-1780
Total Funding:
21.8 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API LetsEncrypt WordPress Domain Not Resolving Wordpress Plugins Euro Organization Schema
Similar Organizations
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Salix Pharmaceuticals
Salix Pharmaceuticals is a specialty pharmaceutical company focused on the prevention and treatment of gastrointestinal disorders.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Company's stock symbol is NASDAQ:NRX
Investors List
East West Bank
East West Bank investment in Post-IPO Equity - NephroGenex
Care Capital
Care Capital investment in Series A - NephroGenex
BioStratum
BioStratum investment in Series A - NephroGenex
Vanderbilt University Office of Investments
Vanderbilt University Office of Investments investment in Series A - NephroGenex
Official Site Inspections
http://www.nephrogenex.com
- Host name: 104.234.36.11
- IP address: 104.234.36.11
- Location: Toronto Canada
- Latitude: 43.7114
- Longitude: -79.4462
- Timezone: America/Toronto
- Postal: M6B
Loading ... 